Table 2.
Baseline and cycle characteristics of patients in both groups.
| Pretreatment group (n=38) | Control group (n=50) | p-value | |
|---|---|---|---|
| Age (years) | 28.07±3.85 | 29.04±4.76 | .313 |
| Duration of infertility (years) | 6.57±3.77 | 5.99±3.74 | .468 |
| AMH | 6.64±1.29 | 6.46±1.01 | .367 |
| End. Thickness at triggering day (mm) | 10.27±1.92 | 10.15±1.98 | .770 |
| Estradiol level at triggering day (ng/ml) | 3323±2670 | 2967±2149 | .491 |
| Gonadotropin Dose (IU) | 1598±1932 | 1515±1475 | .771 |
| Cycle duration (days) | 12.36±1.54 | 13.66±2.23 | .003 |
| COC number | 17.68±9.29 | 16.46±9.76 | .554 |
| Number of M2 oocytes | 14.65±8.30 | 14.10±8.79 | .764 |
| Number of 2PN oocytes | 8.84±6.67 | 7.40±6.41 | .308 |
| Total number of embryos | 7.94±6.16 | 6.94±6.06 | .446 |
| Number of embryos transferred | 2.80±0.7 | 2.69±0.6 | .676 |
| Number of embryos frozen | 3.56±2.10 | 4.13±2.01 | .454 |
Data are presented as mean value ± SD or number (%).